deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03736564

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

68Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Sponsor: Mayo Clinic

Conditions Osteomalacia
Interventions 68Ga-DOTATATE PET/CT
Updated 14 times since 2018 Last updated: Apr 15, 2025 Started: Jan 31, 2019 Primary completion: Oct 31, 2023 Completion: Oct 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Osteomalacia, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 14 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshot~Apr 2019 – ~May 2020 · 13 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Jul 2022 · 10 months · monthly snapshot~Jul 2022 – ~Jun 2023 · 11 months · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~May 2025 · 6 months · monthly snapshot~May 2025 – present · 15 months · monthly snapshot

Change History

14 versions recorded

  1. May 2025 — Present [monthly]

    Completed PHASE1/PHASE2

    Status: Active Not Recruiting → Completed

  2. Nov 2024 — May 2025 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  3. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Aug 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 9 earlier versions

  1. Jun 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Jul 2022 — Jun 2023 [monthly]

    Recruiting PHASE1_PHASE2

  3. Sep 2021 — Jul 2022 [monthly]

    Recruiting PHASE1_PHASE2

  4. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  7. Apr 2019 — May 2020 [monthly]

    Recruiting PHASE1_PHASE2

  8. Feb 2019 — Apr 2019 [monthly]

    Recruiting PHASE1_PHASE2

  9. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations